{"id":"https://openalex.org/W2763435948","doi":"https://doi.org/10.1080/19420862.2017.1389355","title":"Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics","display_name":"Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics","alternate_titles":[],"publication_year":2017,"publication_date":"2017-10-09","ids":{"openalex":"https://openalex.org/W2763435948","doi":"https://doi.org/10.1080/19420862.2017.1389355","mag":"2763435948","pmid":"https://pubmed.ncbi.nlm.nih.gov/28991504","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5800364"},"language":"en","primary_location":{"id":"doi:10.1080/19420862.2017.1389355","doi":"https://doi.org/10.1080/19420862.2017.1389355","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2017.1389355","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2017.1389355?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2763435948"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2017.1389355?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040636499","display_name":"Nicole Piche\u2010Nicholas","orcid":"https://orcid.org/0000-0003-0695-7965","observed_orcids":["https://orcid.org/0000-0003-0695-7965"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nicole M. Piche-Nicholas","raw_affiliation_strings":["BioMedicine Design, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0695-7965","affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058739959","display_name":"Lindsay B. Avery","orcid":"https://orcid.org/0000-0003-4920-8614","observed_orcids":["https://orcid.org/0000-0003-4920-8614"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsay B. Avery","raw_affiliation_strings":["BioMedicine Design, Pfizer Inc., Andover, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-4920-8614","affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Inc., Andover, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033374968","display_name":"Amy C. King","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy C. King","raw_affiliation_strings":["BioMedicine Design, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019351084","display_name":"Mania S. Kavosi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mania Kavosi","raw_affiliation_strings":["BioMedicine Design, Pfizer Inc., Andover, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Inc., Andover, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100429674","display_name":"Mengmeng Wang","orcid":"https://orcid.org/0000-0002-8278-734X","observed_orcids":["https://orcid.org/0000-0002-8278-734X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mengmeng Wang","raw_affiliation_strings":["BioMedicine Design, Pfizer Inc., Andover, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Inc., Andover, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103111596","display_name":"Denise M. O\u2019Hara","orcid":"https://orcid.org/0000-0003-3348-8113","observed_orcids":["https://orcid.org/0000-0003-3348-8113","https://orcid.org/0000-0003-3266-041X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denise M. O'Hara","raw_affiliation_strings":["BioMedicine Design, Pfizer Inc., Andover, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Inc., Andover, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051181862","display_name":"Lioudmila Tchistiakova","orcid":"https://orcid.org/0009-0007-1298-4456","observed_orcids":["https://orcid.org/0009-0007-1298-4456"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lioudmila Tchistiakova","raw_affiliation_strings":["BioMedicine Design, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5115602401","display_name":"Madan Katragadda","orcid":"https://orcid.org/0009-0004-2394-6816","observed_orcids":["https://orcid.org/0009-0004-2394-6816"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Madan Katragadda","raw_affiliation_strings":["BioMedicine Design, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5040636499","https://openalex.org/A5115602401"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":2.8149,"has_fulltext":true,"cited_by_count":85,"citation_normalized_percentile":{"value":0.91267714,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"10","issue":"1","first_page":"81","last_page":"94"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fcrn","display_name":"neonatal Fc receptor","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hypervariable-region","display_name":"hypervariable region","score":0.9829999804496765},{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.6679999828338623},{"id":"https://openalex.org/keywords/variable-domains","display_name":"variable domains","score":0.6940000057220459},{"id":"https://openalex.org/keywords/isoelectric-point","display_name":"isoelectric point","score":0.8880000114440918},{"id":"https://openalex.org/keywords/antibody-clearance","display_name":"antibody clearance","score":0.6779999732971191},{"id":"https://openalex.org/keywords/antibody-optimization","display_name":"antibody optimization","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C2780649865","wikidata":"https://www.wikidata.org/wiki/Q21101413","display_name":"Neonatal Fc receptor","level":4,"score":0.9192548394203186},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6559522151947021},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5968506336212158},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.5945765376091003},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5607502460479736},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.534545361995697},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.49602779746055603},{"id":"https://openalex.org/C106847996","wikidata":"https://www.wikidata.org/wiki/Q898756","display_name":"Surface plasmon resonance","level":3,"score":0.4896705448627472},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4707012176513672},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.44499528408050537},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.42549729347229004},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.417579710483551},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3857564926147461},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3654533624649048},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2535659670829773},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24197468161582947},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08465263247489929},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071184","descriptor_name":"Pharmacogenomic Variants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000918","descriptor_name":"Antibody Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001666","descriptor_name":"Binding Sites, Antibody","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022801","descriptor_name":"Complementarity Determining Regions","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D022801","descriptor_name":"Complementarity Determining Regions","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D022801","descriptor_name":"Complementarity Determining Regions","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D054730","descriptor_name":"Protein Interaction Domains and Motifs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/19420862.2017.1389355","doi":"https://doi.org/10.1080/19420862.2017.1389355","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2017.1389355","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2017.1389355?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5800364","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5800364/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5800364/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:4717132","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5800364","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:28991504","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28991504","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/19420862.2017.1389355","doi":"https://doi.org/10.1080/19420862.2017.1389355","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2017.1389355","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2017.1389355?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2763435948.pdf","grobid_xml":"https://content.openalex.org/works/W2763435948.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1855086894","https://openalex.org/W1929182612","https://openalex.org/W1941707061","https://openalex.org/W1970875728","https://openalex.org/W1972687417","https://openalex.org/W1977937625","https://openalex.org/W1979162895","https://openalex.org/W1983227662","https://openalex.org/W1985960971","https://openalex.org/W1991001030","https://openalex.org/W1996045402","https://openalex.org/W1998744147","https://openalex.org/W2002376314","https://openalex.org/W2009900556","https://openalex.org/W2010801138","https://openalex.org/W2027014013","https://openalex.org/W2034501477","https://openalex.org/W2035742026","https://openalex.org/W2037433854","https://openalex.org/W2038871057","https://openalex.org/W2042951078","https://openalex.org/W2048504768","https://openalex.org/W2051724555","https://openalex.org/W2052789788","https://openalex.org/W2062826169","https://openalex.org/W2069265371","https://openalex.org/W2070556216","https://openalex.org/W2086742633","https://openalex.org/W2089739766","https://openalex.org/W2091887204","https://openalex.org/W2092952127","https://openalex.org/W2093529351","https://openalex.org/W2100195091","https://openalex.org/W2104198642","https://openalex.org/W2104446771","https://openalex.org/W2108348023","https://openalex.org/W2108740939","https://openalex.org/W2109167399","https://openalex.org/W2113261643","https://openalex.org/W2113701404","https://openalex.org/W2126339873","https://openalex.org/W2138906847","https://openalex.org/W2149725620","https://openalex.org/W2158062848","https://openalex.org/W2171136826","https://openalex.org/W2209221218","https://openalex.org/W2400018431","https://openalex.org/W2501322479","https://openalex.org/W2570172057","https://openalex.org/W2626346231","https://openalex.org/W4210966619","https://openalex.org/W4253085957"],"related_works":["https://openalex.org/W594833753","https://openalex.org/W3093264635","https://openalex.org/W2034501477","https://openalex.org/W2104446771","https://openalex.org/W2108883201","https://openalex.org/W7133297915","https://openalex.org/W1929182612","https://openalex.org/W2009701454","https://openalex.org/W1977937625"],"abstract_inverted_index":{"A":[0],"large":[1],"body":[2],"of":[3,13,26,33,71,97,106,119,123,155,186,203,206,222,226,238,247],"data":[4],"exists":[5],"demonstrating":[6],"that":[7,31,50,135],"neonatal":[8],"Fc":[9,18,43,55],"receptor":[10],"(FcRn)":[11],"binding":[12,60,94,146,166],"an":[14],"IgG":[15,34,73,80,98,107,131,156,207,227,239,248],"via":[16],"its":[17],"CH2-CH3":[19],"interface":[20],"trends":[21],"with":[22,181,198],"the":[23,54,69,77,92,104,111,177,220,245],"pharmacokinetics":[24],"(PK)":[25],"IgG.":[27,116],"We":[28],"have":[29,241],"observed":[30],"PK":[32,237],"molecules":[35,99,157,208],"vary":[36],"widely,":[37],"even":[38],"when":[39],"they":[40],"share":[41],"identical":[42],"domains.":[44],"This":[45],"led":[46],"us":[47],"to":[48,58,90,100,148,168,174,229],"hypothesize":[49],"domains":[51,74,108,189],"distal":[52],"from":[53],"could":[56],"contribute":[57],"FcRn":[59,114,149,169,216,230],"and":[61,81,115,138,176,190,233],"affect":[62],"PK.":[63],"In":[64,192],"this":[65],"study,":[66],"we":[67,102,133],"explored":[68],"role":[70,221],"these":[72],"in":[75,109,139,150,163,170,200,214,224,231,244],"altering":[76],"affinity":[78,95,112,147,167,178,195,228],"between":[79,113],"FcRn.":[82],"Using":[83],"a":[84,120,153,204],"surface":[85],"plasmon":[86],"resonance-based":[87],"assay":[88],"developed":[89],"examine":[91],"steady-state":[93],"(KD)":[96],"FcRn,":[101],"dissected":[103],"contributions":[105],"modulating":[110],"Through":[117],"analysis":[118],"broad":[121],"collection":[122],"therapeutic":[124],"antibodies":[125],"containing":[126],"more":[127],"than":[128],"50":[129],"unique":[130],"molecules,":[132],"demonstrated":[134],"variable":[136,188],"domains,":[137],"particular":[140],"complementarity-determining":[141],"regions":[142],"(CDRs),":[143],"significantly":[144],"alter":[145],"vitro.":[151],"Furthermore,":[152],"panel":[154],"differing":[158,209],"only":[159,210],"by":[160,172,211],"1\u20135":[161],"mutations":[162,213],"CDRs":[164,223],"altered":[165],"vitro,":[171],"up":[173],"79-fold,":[175],"values":[179,185,196],"correlated":[180],"calculated":[182],"isoelectric":[183],"point":[184],"both":[187],"CDR-L3.":[191],"addition,":[193],"tighter":[194],"trend":[197],"faster":[199],"vivo":[201],"clearance":[202],"set":[205],"1\u20133":[212],"human":[215],"transgenic":[217],"mice.":[218],"Understanding":[219],"modulation":[225],"vitro":[232],"their":[234],"effect":[235],"on":[236],"may":[240],"far-reaching":[242],"implications":[243],"optimization":[246],"therapeutics.":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2763435948","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2017-10-20T00:00:00"}
